Chart calendar Navidea Biopharmaceuticals Inc
Upcoming events on Navidea Biopharmaceuticals Inc
Past events on Navidea Biopharmaceuticals Inc
16/11/2023 11:30 pm | Annual General Meeting |
14/11/2023 | Q3 2023 Earnings Release |
27/07/2023 10:30 pm | Extraordinary Shareholders Meeting |
08/06/2023 01:30 am | Q1 2023 Earnings Release |
22/03/2023 02:30 am | Q4 2022 Earnings Call |
22/03/2023 01:31 am | Q4 2022 Earnings Release |
08/12/2022 11:30 pm | Annual General Meeting |
16/11/2022 03:30 am | Q3 2022 Earnings Call |
14/11/2022 06:30 pm | Q3 2022 Earnings Release |
10/11/2022 07:30 pm | Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161 |
10/11/2022 | American College of Rheumatology Convergence Conference |
09/09/2022 01:30 am | Interim 2022 Earnings Call |
15/08/2022 06:00 pm | Interim 2022 Earnings Release |
12/06/2022 06:30 am | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197 |
13/05/2022 02:30 am | Q1 2022 Earnings Call |
12/05/2022 05:00 pm | Q1 2022 Earnings Release |
21/04/2022 02:30 am | NAV3-32 Phase 2B Study Results Call |
15/04/2022 02:30 am | Business Update Call |
24/03/2022 02:30 am | FY 2021 Earnings Call |
23/03/2022 05:00 pm | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,17 | 0,66 0,77 -14.18% | 0,92 0,90 2.18% |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -11,0 -11,0 0.09% | -10,7 -12,1 11.2% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.17% | -10,7 -12,1 11.02% |
Net income Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.16% | -11,4 -12,1 5.51% |
EPS USD | Released Forecast Spread | -1,80 | -0,76 -0,74 -3.4% | -0,48 -0,48 0% |
Announcement Date | - | 11/03/20 | 24/03/21 |
Quarterly results
Fiscal Period | December | 2021 Q3 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - |
EBIT Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
Net income Million USD | Released Forecast Spread | -2,44 -3,52 30.8% |
EPS USD | Released Forecast Spread | -0,08 -0,11 27.27% |
Announcement Date | 10/11/21 |
15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Navidea Biopharmaceuticals Inc
07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |